CCL2 and neoplasm: Studies in multiple cancers such as breast, prostate, and colon have shown a direct role for MCP-1 in increased proliferation of tumor cells (16, 17) and studies with MCP-1 receptor knockout mice or MCP-1 blockade have demonstrated a reduction in tumor size (18, 19).